NCT03150888

Multi-provincial Cohort for Hypertension (MUCH)

Multi-provincial Cohort for Hypertension in China

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30,000 (estimated)
• Sponsor: Beijing Institute of Heart, Lung and Blood Vessel Diseases · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to construct hypertension specialized cohort using uniform standards and specifications. This study timely collected multi-dimensional clinical information through electronic medical records, mobile health, data integration, informatics and computer modern techniques, linking self-reported data and big data platforms from different sources to timely obtain the incidence and mortality data, and integrating hypertension cohort samples and the associated clinical records systematically, in order to build a 30-thousand hypertension specialized cohort with fine phenotypic data and blood/urine samples, thus far to provide support for the development of precise medicine research and related industries.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Antihypertensive Agents	Single or combination therapy with five type of antihypertensive agents, such as Ca channel blockers, ACE inhibitors, ARBs, diuretics, or beta-blockers.
OTHER	Cardiovascular risk factors	Different level of cardiovascular risk factors associated with genetics, environments and lifestyles.

Timeline

• Start date: 2017-07-03
• Primary completion: 2020-12-01
• Completion: 2020-12-01
• First posted: 2017-05-12
• Last updated: 2020-01-22

Locations

6 sites across 1 country: China